249 related articles for article (PubMed ID: 29462634)
1. Labrasol
Heade J; Maher S; Bleiel SB; Brayden DJ
J Pharm Sci; 2018 Jun; 107(6):1648-1655. PubMed ID: 29462634
[TBL] [Abstract][Full Text] [Related]
2. Efficacious intestinal permeation enhancement induced by the sodium salt of 10-undecylenic acid, a medium chain fatty acid derivative.
Brayden DJ; Walsh E
AAPS J; 2014 Sep; 16(5):1064-76. PubMed ID: 24961919
[TBL] [Abstract][Full Text] [Related]
3. Labrasol® is an efficacious intestinal permeation enhancer across rat intestine: Ex vivo and in vivo rat studies.
McCartney F; Jannin V; Chevrier S; Boulghobra H; Hristov DR; Ritter N; Miolane C; Chavant Y; Demarne F; Brayden DJ
J Control Release; 2019 Sep; 310():115-126. PubMed ID: 31401199
[TBL] [Abstract][Full Text] [Related]
4. Thiolated polycarbophil/glutathione: defining its potential as a permeation enhancer for oral drug administration in comparison to sodium caprate.
Perera G; Barthelmes J; Vetter A; Krieg C; Uhlschmied C; Bonn GK; Bernkop-Schnürch A
Drug Deliv; 2011 Aug; 18(6):415-23. PubMed ID: 21554106
[TBL] [Abstract][Full Text] [Related]
5. Development of a Non-Aqueous Dispersion to Improve Intestinal Epithelial Flux of Poorly Permeable Macromolecules.
Maher S; Medani M; Carballeira NN; Winter DC; Baird AW; Brayden DJ
AAPS J; 2017 Jan; 19(1):244-253. PubMed ID: 27739012
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of the intestinal permeation enhancers, SNAC and sodium caprate (C
Twarog C; McCartney F; Harrison SM; Illel B; Fattal E; Brayden DJ
Eur J Pharm Sci; 2021 Mar; 158():105685. PubMed ID: 33359131
[TBL] [Abstract][Full Text] [Related]
7. Sodium caprate-induced increases in intestinal permeability and epithelial damage are prevented by misoprostol.
Brayden DJ; Maher S; Bahar B; Walsh E
Eur J Pharm Biopharm; 2015 Aug; 94():194-206. PubMed ID: 26026287
[TBL] [Abstract][Full Text] [Related]
8. Impact of Intestinal Concentration and Colloidal Structure on the Permeation-Enhancing Efficiency of Sodium Caprate in the Rat.
Berg S; Kärrberg L; Suljovic D; Seeliger F; Söderberg M; Perez-Alcazar M; Van Zuydam N; Abrahamsson B; Hugerth AM; Davies N; Bergström CAS
Mol Pharm; 2022 Jan; 19(1):200-212. PubMed ID: 34928160
[TBL] [Abstract][Full Text] [Related]
9. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Makhlof A; Werle M; Tozuka Y; Takeuchi H
J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae.
Maher S; Kennelly R; Bzik VA; Baird AW; Wang X; Winter D; Brayden DJ
Eur J Pharm Sci; 2009 Nov; 38(4):291-300. PubMed ID: 19737613
[TBL] [Abstract][Full Text] [Related]
11. Effects of surfactant-based permeation enhancers on mannitol permeability, histology, and electrogenic ion transport responses in excised rat colonic mucosae.
Maher S; Heade J; McCartney F; Waters S; Bleiel SB; Brayden DJ
Int J Pharm; 2018 Mar; 539(1-2):11-22. PubMed ID: 29341916
[TBL] [Abstract][Full Text] [Related]
12. Restoration of rat colonic epithelium after in situ intestinal instillation of the absorption promoter, sodium caprate.
Wang X; Maher S; Brayden DJ
Ther Deliv; 2010 Jul; 1(1):75-82. PubMed ID: 22816121
[TBL] [Abstract][Full Text] [Related]
13. Investigation of coco-glucoside as a novel intestinal permeation enhancer in rat models.
Aguirre TA; Rosa M; Guterres SS; Pohlmann AR; Coulter I; Brayden DJ
Eur J Pharm Biopharm; 2014 Nov; 88(3):856-65. PubMed ID: 25445305
[TBL] [Abstract][Full Text] [Related]
14. The effects of common solubilizing agents on the intestinal membrane barrier functions and membrane toxicity in rats.
Hamid KA; Katsumi H; Sakane T; Yamamoto A
Int J Pharm; 2009 Sep; 379(1):100-8. PubMed ID: 19555752
[TBL] [Abstract][Full Text] [Related]
15. A head-to-head Caco-2 assay comparison of the mechanisms of action of the intestinal permeation enhancers: SNAC and sodium caprate (C
Twarog C; Liu K; O'Brien PJ; Dawson KA; Fattal E; Illel B; Brayden DJ
Eur J Pharm Biopharm; 2020 Jul; 152():95-107. PubMed ID: 32387703
[TBL] [Abstract][Full Text] [Related]
16. Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers.
Huang A; Su Z; Li S; Sun M; Xiao Y; Ping Q; Deng Y
Drug Deliv; 2014 Aug; 21(5):388-96. PubMed ID: 24188463
[TBL] [Abstract][Full Text] [Related]
17. In vitro interactions between the oral absorption promoter, sodium caprate (C(10)) and S. typhimurium in rat intestinal ileal mucosae.
Cox AB; Rawlinson LA; Baird AW; Bzik V; Brayden DJ
Pharm Res; 2008 Jan; 25(1):114-22. PubMed ID: 17546408
[TBL] [Abstract][Full Text] [Related]
18. Water-in-oil microemulsions containing medium-chain fatty acids/salts: formulation and intestinal absorption enhancement evaluation.
Constantinides PP; Welzel G; Ellens H; Smith PL; Sturgis S; Yiv SH; Owen AB
Pharm Res; 1996 Feb; 13(2):210-5. PubMed ID: 8932438
[TBL] [Abstract][Full Text] [Related]
19. Thiolated chitosans: influence of various sulfhydryl ligands on permeation-enhancing and P-gp inhibitory properties.
Sakloetsakun D; Iqbal J; Millotti G; Vetter A; Bernkop-Schnürch A
Drug Dev Ind Pharm; 2011 Jun; 37(6):648-55. PubMed ID: 21561400
[TBL] [Abstract][Full Text] [Related]
20. Salcaprozate sodium (SNAC) enhances permeability of octreotide across isolated rat and human intestinal epithelial mucosae in Ussing chambers.
Fattah S; Ismaiel M; Murphy B; Rulikowska A; Frias JM; Winter DC; Brayden DJ
Eur J Pharm Sci; 2020 Nov; 154():105509. PubMed ID: 32777258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
